|
RNF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.5410000000018E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.062900E-03 |
| Normal-vs-Stage2 |
1.272820E-01 |
| Normal-vs-Stage3 |
8.69229999977961E-07 |
| Normal-vs-Stage4 |
4.224600E-03 |
| Stage1-vs-Stage2 |
9.878800E-01 |
| Stage1-vs-Stage3 |
4.584700E-03 |
| Stage1-vs-Stage4 |
2.579600E-01 |
| Stage2-vs-Stage3 |
1.136390E-01 |
| Stage2-vs-Stage4 |
4.459400E-01 |
| Stage3-vs-Stage4 |
3.677800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.033200E-04 |
| Normal-vs-AfricanAmerican |
5.883500E-03 |
| Normal-vs-Asian |
7.064600E-01 |
| Caucasian-vs-AfricanAmerican |
6.840200E-01 |
| Caucasian-vs-Asian |
5.575400E-01 |
| AfricanAmerican-vs-Asian |
4.700600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5731999999955E-06 |
| Normal-vs-Female |
4.291900E-02 |
| Male-vs-Female |
1.201630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.006800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.055890E-02 |
| Normal-vs-Age(61-80Yrs) |
5.66349999999716E-05 |
| Normal-vs-Age(81-100Yrs) |
6.221200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.954430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.225400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.351200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.426170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.506590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.112400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.110800E-01 |
| Normal-vs-Grade 2 |
4.679600E-02 |
| Normal-vs-Grade 3 |
3.41260000036314E-07 |
| Normal-vs-Grade 4 |
4.423900E-04 |
| Grade 1-vs-Grade 2 |
1.635830E-01 |
| Grade 1-vs-Grade 3 |
3.204600E-03 |
| Grade 1-vs-Grade 4 |
2.484200E-02 |
| Grade 2-vs-Grade 3 |
1.100020E-03 |
| Grade 2-vs-Grade 4 |
1.795930E-02 |
| Grade 3-vs-Grade 4 |
7.853400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.368400E-01 |
| Normal-vs-ccB subtype |
2.38969999999394E-06 |
| ccA subtype-vs-ccB subtype |
1.387630E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.838600E-04 |
| Normal-vs-N1 |
1.291580E-01 |
| N0-vs-N1 |
8.444000E-01 |
|
|
